###begin article-title 0
Fetuin-A Induces Cytokine Expression and Suppresses Adiponectin Production
###end article-title 0
###begin p 1
Conceived and designed the experiments: HH HS FM NS AF AH CW. Performed the experiments: HS NS AH. Analyzed the data: HS NS AF AH. Contributed reagents/materials/analysis tools: HS FM NS AH CW. Wrote the paper: HH HS NS AH.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
The secreted liver protein fetuin-A (AHSG) is up-regulated in hepatic steatosis and the metabolic syndrome. These states are strongly associated with low-grade inflammation and hypoadiponectinemia. We, therefore, hypothesized that fetuin-A may play a role in the regulation of cytokine expression, the modulation of adipose tissue expression and plasma concentration of the insulin-sensitizing and atheroprotective adipokine adiponectin.
###end p 3
###begin title 4
Methodology and Principal Findings
###end title 4
###begin p 5
###xml 37 45 37 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 415 418 415 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF</italic>
###xml 423 427 423 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
###xml 562 565 562 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tnf</italic>
###xml 582 585 582 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il6</italic>
###xml 694 700 694 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Adipoq</italic>
###xml 806 812 806 812 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADIPOQ</italic>
###xml 838 846 838 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 31 36 <span type="species:ncbi:9606">human</span>
###xml 92 96 <span type="species:ncbi:10090">mice</span>
###xml 481 485 <span type="species:ncbi:10090">mice</span>
###xml 832 837 <span type="species:ncbi:9606">human</span>
###xml 931 937 <span type="species:ncbi:9606">humans</span>
Human monocytic THP1 cells and human in vitro differenttiated adipocytes as well as C57BL/6 mice were treated with fetuin-A. mRNA expression of the genes encoding inflammatory cytokines and the adipokine adiponectin (ADIPOQ) was assessed by real-time RT-PCR. In 122 subjects, plasma levels of fetuin-A, adiponectin and, in a subgroup, the multimeric forms of adiponectin were determined. Fetuin-A treatment induced TNF and IL1B mRNA expression in THP1 cells (p<0.05). Treatment of mice with fetuin-A, analogously, resulted in a marked increase in adipose tissue Tnf mRNA as well as Il6 expression (27- and 174-fold, respectively). These effects were accompanied by a decrease in adipose tissue Adipoq mRNA expression and lower circulating adiponectin levels (p<0.05, both). Furthermore, fetuin-A repressed ADIPOQ mRNA expression of human in vitro differentiated adipocytes (p<0.02) and induced inflammatory cytokine expression. In humans in plasma, fetuin-A correlated positively with high-sensitivity C-reactive protein, a marker of subclinical inflammation (r = 0.26, p = 0.01), and negatively with total- (r = -0.28, p = 0.02) and, particularly, high molecular weight adiponectin (r = -0.36, p = 0.01).
###end p 5
###begin title 6
Conclusions and Significance
###end title 6
###begin p 7
###xml 153 159 <span type="species:ncbi:9606">humans</span>
We provide novel evidence that the secreted liver protein fetuin-A induces low-grade inflammation and represses adiponectin production in animals and in humans. These data suggest an important role of fatty liver in the pathophysiology of insulin resistance and atherosclerosis.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 50 51 46 47 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 117 120 113 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Dziegielewska1">[1]</xref>
###xml 185 188 181 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Denecke1">[2]</xref>
###xml 328 331 324 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Auberger1">[3]</xref>
###xml 332 335 328 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Mathews2">[7]</xref>
###xml 490 493 486 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Mathews3">[8]</xref>
###xml 821 824 817 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Siddiq1">[9]</xref>
###xml 874 878 870 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Dahlman1">[10]</xref>
###xml 954 958 950 954 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Schmidt1">[11]</xref>
###xml 30 35 <span type="species:ncbi:9606">human</span>
###xml 350 354 <span type="species:ncbi:10090">mice</span>
###xml 748 753 <span type="species:ncbi:9606">human</span>
Fetuin-A (former name for the human protein: alpha2-Heremans-Schmid glycoprotein, AHSG) is an abundant serum protein [1] that is exclusively produced by the liver, tongue, and placenta [2]. In several studies, fetuin-A was shown to act as a natural inhibitor of the insulin receptor tyrosine kinase in liver and skeletal muscle [3]-[7]. In addition, mice deficient for the gene encoding fetuin-A displayed improved insulin sensitivity and were resistant to weight gain upon a high-fat diet [8]. Besides these well-documented effects of fetuin-A on the insulin receptor of muscle and liver, another mechanism of this protein may include effects on adipose tissue to induce whole-body insulin resistance. Recently, polymorphisms in the gene encoding human fetuin-A were found to be not only associated with type 2 diabetes [9], but also to affect insulin action in adipocytes [10]. Furthermore, fetuin-A was shown to exert direct pro-adipogenic properties [11], however, the underlying mechanisms are unknown.
###end p 9
###begin p 10
###xml 35 39 35 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AHSG</italic>
###xml 64 70 64 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADIPOQ</italic>
###xml 204 208 204 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Kadowaki1">[12]</xref>
###xml 209 213 209 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Bacha1">[16]</xref>
###xml 241 245 241 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Pischon1">[17]</xref>
###xml 246 250 246 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Rothenbacher1">[20]</xref>
###xml 414 418 414 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Vionnet1">[21]</xref>
###xml 420 424 420 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Kissebah1">[22]</xref>
###xml 497 501 497 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Pollin1">[23]</xref>
###xml 613 619 613 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADIPOQ</italic>
###xml 625 629 625 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Pollin1">[23]</xref>
###xml 737 741 737 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AHSG</italic>
###xml 19 24 <span type="species:ncbi:9606">human</span>
###xml 45 50 <span type="species:ncbi:9606">human</span>
The genes encoding human fetuin-A (AHSG) and human adiponectin (ADIPOQ), which is almost exclusively secreted from adipose tissue and represents an important determinant of whole-body insulin sensitivity [12]-[16] and cardiovascular disease [17]-[20], are located next to each other on chromosome 3q27. This chromosomal region was previously mapped as a type 2 diabetes and metabolic syndrome susceptibility locus [21], [22], and also shows close linkage to variation in plasma adiponectin levels [23]. However, not all of the variability in plasma adiponectin levels can be explained by genetic variation of the ADIPOQ gene [23]. Therefore, other genes under this linkage peak may encode proteins regulating adiponectin production with AHSG representing a major candidate.
###end p 10
###begin p 11
###xml 153 157 153 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Stefan2">[24]</xref>
###xml 159 163 159 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Mori1">[25]</xref>
###xml 327 331 327 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Ix1">[26]</xref>
###xml 422 426 422 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Trujillo1">[27]</xref>
###xml 473 477 473 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AHSG</italic>
###xml 40 45 <span type="species:ncbi:9606">human</span>
###xml 213 218 <span type="species:ncbi:9606">human</span>
Recently, we and others have shown that human plasma fetuin-A levels are correlated with fatty liver, impaired glucose tolerance, and insulin resistance [24], [25]. Moreover, a recent study provided evidence that human plasma fetuin-A levels are strongly associated with the metabolic syndrome and an atherogenic lipid profile [26]. Since these states are characterized by subclinical inflammation and hypoadiponectinemia [27], and based on the chromosomal localization of AHSG, we investigated whether fetuin-A regulates cytokine expression, modulates adipose tissue expression and the plasma concentration of the insulin-sensitizing and atheroprotective adipokine adiponectin.
###end p 11
###begin title 12
Material and Methods
###end title 12
###begin title 13
Cell culture
###end title 13
###begin p 14
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 291 296 <span type="species:ncbi:9606">human</span>
###xml 388 393 <span type="species:ncbi:9606">human</span>
Human THP1 monocytes were obtained from American Type Culture Collection (Manassas, VA, USA) and cultured in IMDM supplemented with 10% (v/v) FCS, 100 IU/ml penicillin, 0.1 mg/ml streptomycin, and 2 mmol/l glutamine. Cells were left untreated or stimulated for 8 and 24 h with 600 microg/ml human fetuin-A (purity >/=95%, Sigma-Aldrich, Steinheim, Germany), a high physiological dose, or human serum albumin for control (ZLB Behring, Marburg, Germany), respectively.
###end p 14
###begin p 15
###xml 99 103 99 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Schling1">[28]</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 332 339 <span type="species:ncbi:9031">chicken</span>
###xml 1425 1430 <span type="species:ncbi:9606">human</span>
###xml 1434 1440 <span type="species:ncbi:9913">bovine</span>
Human preadipocytes were isolated from abdominal subcutaneous fat biopsies as previously described [28]. The donors underwent abdominal surgery for clinical purposes and gave informed written consent to the study. Isolated preadipocytes were expanded in alpha-MEM/Ham's nutrient mixture F12 (1:1) containing 20% (v/v) FCS, 1% (v/v) chicken embryo extract (Sera Laboratories International, Horsted Keynes, UK), 100 IU/ml penicillin, 0.1 mg/ml streptomycin, 0.5 microg/ml fungizone, and 2 mmol/l glutamine. First-pass cells were used for the experiments. At confluence, adipose conversion was induced by shifting the cells into DMEM/Ham's nutrient mixture F12 (1:1), 5% (v/v) FCS, 17 micromol/l pantothenate, 1 micromol/l biotin, 2 microg/ml apo-transferrin, 1 micromol/l insulin, 100 IU/ml penicillin, 0.1 mg/ml streptomycin, 0.5 microg/ml fungizone, and 2 mmol/l glutamine (differentiation medium) supplemented with 0.5 mmol/l 3-isobutyl-1-methyl-xanthine, 1 micromol/l cortisol, 10 micromol/l troglitazone, and 50 micromol/l indomethacin for 7 days. Finally, the cells were allowed to terminally differentiate for another 7 days in differentiation medium without supplements. Medium was changed three times a week. In vitro differentiated adipocytes were washed once with PBS and pretreated overnight with insulin- and FCS-free differentiation medium. Thereafter, cells were incubated for 24 h with or without 300 microg/ml human or bovine fetuin-A, respectively, in insulin- and FCS-free differentiation medium prior to RNA isolation. The procedures were approved by the Ethical Committee of the Tubingen University Medical Department.
###end p 15
###begin title 16
Animal studies
###end title 16
###begin p 17
###xml 954 958 930 934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Matthews1">[29]</xref>
###xml 13 17 <span type="species:ncbi:10090">mice</span>
###xml 130 134 <span type="species:ncbi:10090">mice</span>
###xml 195 201 <span type="species:ncbi:9913">bovine</span>
###xml 319 324 <span type="species:ncbi:9606">human</span>
###xml 361 366 <span type="species:ncbi:9606">human</span>
Male C57BL/6 mice were obtained from Charles River Laboratories (Sulzfeld, Germany). For in vivo stimulation, 12-week-old C57BL/6 mice kept on a regular diet obtained an intraperitoneal bolus of bovine fetuin-A (fetuin-I, Pedersen's preparation, purity approximately75%, 0.75 mg/g body weight, ICN, Eschwege, Germany), human fetuin-A (0.5 mg/g body weight), or human serum albumin (0.5 mg/g body weight), respectively. Controls received a comparable amount of diluent (n >/= 3 each). Serum and perigonadal adipose tissue were removed after 8 h. Tissue samples were stored at 4degreesC in RNAlater (Ambion, Huntingdon, United Kingdom). All procedures were conducted according to the guidelines of laboratory animal care and were approved by the local governmental commission for animal research. Insulin resistance was estimated by the homeostasis model assessment of insulin resistance (HOMA-IR) and calculated as insulin (microU/ml) . glucose (mM)/22.5 [29].
###end p 17
###begin title 18
Real-time RT-PCR
###end title 18
###begin p 19
###xml 878 885 878 885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001765-t001">Table 1</xref>
###xml 41 46 <span type="species:ncbi:10090">mouse</span>
###xml 215 220 <span type="species:ncbi:9606">human</span>
###xml 473 476 <span type="species:ncbi:11866?0.5863095238095238|species:ncbi:12321?0.21726190476190477">AMV</span>
For quantification of mRNA expression in mouse adipose tissue, RNA was isolated with peqGOLD TriFast according to the manufacturer's instructions (Peqlab, Erlangen, Germany). For quantification of THP1 monocyte and human adipocyte mRNA, cells were washed, harvested, and RNA was isolated with RNeasy silica-gel columns according to the manufacturer's instructions (Qiagen, Hilden, Germany). The total RNA was treated with RNase-free DNase I and transcribed into cDNA using AMV reverse transcriptase and the first strand cDNA kit from Roche Diagnostics (Mannheim, Germany). Quantitative PCR was performed with SYBR Green I dye on a high speed thermal cycler with integrated microvolume fluorometer according to the instructions of the manufacturer (Roche Diagnostics, Mannheim, Germany). Primers were obtained from Invitrogen (Karlsruhe, Germany) and PCR conditions are given in Table 1. Measurements were performed in triplicate. Cellular mRNA contents are given, after correction for 28S-rRNA, in relative arbitrary units (RAU or % of control).
###end p 19
###begin title 20
Conditions for RT-PCR quantification of specific mRNAs and 28S-rRNA.
###end title 20
###begin p 21
###xml 17 21 17 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
###xml 62 94 62 94 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AGGTGCTCAGGTCATTCTCCTGG-FL-3&#8242;</named-content>
###xml 99 135 99 135 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-Red640-AGGTCTGTGGGCAGGGAACC-PH-3&#8242;</named-content>
For detection of IL1B mRNA, the fluorescent dye-linked probes 5'-AGGTGCTCAGGTCATTCTCCTGG-FL-3' and 5'-Red640-AGGTCTGTGGGCAGGGAACC-PH-3' were used instead of SYBR Green.
###end p 21
###begin title 22
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human subjects
###end title 22
###begin p 23
###xml 136 140 136 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Stefan2">[24]</xref>
###xml 243 255 <span type="species:ncbi:9606">participants</span>
###xml 389 401 <span type="species:ncbi:9606">participants</span>
A total of 122 individuals were studied. These subjects were at increased risk for type 2 diabetes and participated in an ongoing study [24]. Individuals were recruited from the southern part of Germany and were not related to each other. The participants did not take any medication known to affect glucose tolerance or insulin sensitivity. Informed written consent was obtained from all participants, and the Ethical Committee of the Tubingen University Medical Department had approved the protocol.
###end p 23
###begin title 24
Hyperinsulinemic euglycemic clamp
###end title 24
###begin p 25
###xml 80 84 80 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Stefan2">[24]</xref>
###xml 160 162 160 162 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;2</sup>
###xml 166 168 166 168 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 408 410 404 406 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 414 416 410 412 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 419 421 415 417 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 485 487 481 483 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 491 493 487 489 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 41 46 <span type="species:ncbi:9606">human</span>
Insulin sensitivity was determined in 49 human subjects as previously described [24]. In brief, subjects received a primed insulin infusion at a rate of 40 mU.m-2.min-1 for 2 h. Plasma was drawn every 5 min for determination of plasma glucose, and glucose infusion was adjusted appropriately to maintain the fasting glucose level. An insulin sensitivity index for systemic glucose uptake (ISI; in micromol kg-1 min-1 pM-1) was calculated as the mean infusion rate of glucose (in mol kg-1 min-1) necessary to maintain euglycemia during the last 40 min of the hyperinsulinemic euglycemic clamp divided by the steady state plasma insulin concentration. The latter was the mean insulin concentration at min 100, 110, and 120 of the clamp (522+/-19 pM).
###end p 25
###begin title 26
Other analytical procedures
###end title 26
###begin p 27
###xml 262 266 <span type="species:ncbi:10090">mice</span>
###xml 305 310 <span type="species:ncbi:9606">human</span>
###xml 635 641 <span type="species:ncbi:9606">humans</span>
Plasma glucose was determined using a bedside glucose analyzer (glucose oxidase method; Yellow Springs Instruments, Yellow Springs, CO, USA). Plasma insulin was determined by an enzyme immunoassay (Abbott Laboratories, Tokyo, Japan). Serum adiponectin levels in mice and fasting plasma fetuin-A levels in human subjects were measured using commercial enzyme-linked immunosorbent assays (ELISA, BioVendor Laboratory Medicine, Brno, Czech Republic). ELISAs were also used to measure serum concentrations of TNF-alpha, IL-6, and high sensitivity C-reactive protein (hsCRP, R&D Systems Inc., MN, USA). Fasting plasma adiponectin levels in humans were determined by radioimmunoassay (LINCO Research, St. Charles, MO, USA). Multimeric forms of adiponectin were quantified using an enzyme immunoassay (ALPCO Diagnostics, Salem, NH, USA). Percentage of body fat was assessed by bioelectrical impedance.
###end p 27
###begin title 28
Statistical analyses
###end title 28
###begin p 29
Data are given as means+/-SEM. For 3-group comparisons, data were analyzed by ANOVA followed by Dunnett's test. Statistical comparison between treatment and control group were performed with the Student's t-test. To adjust for the effects of relevant covariates (age, gender, body fat) in the in vivo data, multivariate linear regression analysis was performed using log-transformed data. A p-value <0.05 was considered statistically significant. The statistical software package JMP 4.0 (SAS Institute Inc, Cary, NC, USA) was used.
###end p 29
###begin title 30
Results
###end title 30
###begin title 31
###xml 50 55 <span type="species:ncbi:9606">human</span>
Effect of fetuin-A on cytokine mRNA expression of human THP1 monocytes
###end title 31
###begin p 32
###xml 261 264 257 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF</italic>
###xml 301 310 297 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001765-g001">Figure 1A</xref>
###xml 316 320 312 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
###xml 357 366 353 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001765-g001">Figure 1B</xref>
###xml 409 414 405 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PBEF1</italic>
###xml 435 444 431 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001765-g001">Figure 1C</xref>
###xml 449 453 445 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RETN</italic>
###xml 474 483 470 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001765-g001">Figure 1D</xref>
###xml 576 587 572 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001765-g001">Figure 1A&#8211;D</xref>
###xml 594 597 590 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL6</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 39 44 <span type="species:ncbi:9606">human</span>
###xml 170 175 <span type="species:ncbi:9606">human</span>
###xml 215 220 <span type="species:ncbi:9606">Human</span>
###xml 486 491 <span type="species:ncbi:9606">Human</span>
Human THP1 monocytes were treated with human fetuin-A and, to evaluate the specificity of fetuin-A's effect and as control for general trophic effects, additionally with human albumin (600 microg/ml, each) for 8 h. Human fetuin-A induced the mRNA expression of TNF (ANOVA, F(14,12) = 9.07, p = 0.004, Figure 1A) and IL1B (ANOVA, F(14,12) = 4.27, p = 0.075, Figure 1B), but did not modulate mRNA expression of PBEF1 (encoding visfatin, Figure 1C) or RETN (encoding resistin, Figure 1D). Human albumin as a control did not significantly alter the expression of all these genes (Figure 1A-D). The IL6 mRNA expression in these cells was below the detection limit.
###end p 32
###begin title 33
###xml 19 24 <span type="species:ncbi:9606">human</span>
mRNA expression in human THP1 monocytes following fetuin-A treatment.
###end title 33
###begin p 34
###xml 14 17 14 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF</italic>
###xml 23 27 23 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
###xml 33 38 33 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PBEF1</italic>
###xml 48 52 48 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RETN</italic>
###xml 65 70 <span type="species:ncbi:9606">human</span>
###xml 128 133 <span type="species:ncbi:9606">human</span>
###xml 145 150 <span type="species:ncbi:9606">human</span>
Expression of TNF (A), IL1B (B), PBEF1 (C), and RETN (D) mRNA in human THP1 monocytes before (control) and after treatment with human albumin or human fetuin-A for 8 h. Cellular mRNA contents were corrected for 28S-rRNA (RAU = relative arbitrary units). Data are given as means+/-SEM (n = 5). Data were analyzed by ANOVA, followed by Dunnett's test.
###end p 34
###begin title 35
###xml 91 95 <span type="species:ncbi:10090">mice</span>
Effect of fetuin-A on adipose tissue Adipoq mRNA expression and circulating adiponectin in mice
###end title 35
###begin p 36
###xml 342 345 338 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il6</italic>
###xml 350 353 346 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tnf</italic>
###xml 449 460 445 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001765-g002">Figure 2A,B</xref>
###xml 520 526 516 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Adipoq</italic>
###xml 597 606 593 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001765-g002">Figure 2C</xref>
###xml 719 725 715 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Adipoq</italic>
###xml 995 1001 991 997 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Adipoq</italic>
###xml 1423 1426 1419 1422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lep</italic>
###xml 1449 1453 1445 1449 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rbp4</italic>
###xml 1518 1521 1514 1517 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lep</italic>
###xml 1523 1532 1519 1528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001765-g002">Figure 2D</xref>
###xml 1537 1541 1533 1537 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rbp4</italic>
###xml 1710 1721 1706 1717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001765-g002">Figure 2A&#8211;D</xref>
###xml 52 57 <span type="species:ncbi:9606">human</span>
###xml 108 112 <span type="species:ncbi:10090">mice</span>
###xml 854 858 <span type="species:ncbi:10090">mice</span>
###xml 889 895 <span type="species:ncbi:9913">bovine</span>
###xml 1276 1280 <span type="species:ncbi:10090">mice</span>
###xml 1589 1593 <span type="species:ncbi:10090">mice</span>
###xml 1599 1604 <span type="species:ncbi:9606">human</span>
Within 8 h, intraperitoneal bolus administration of human fetuin-A (0.5 mg/g body weight) into male C57BL/6 mice resulted in insulin resistance (fetuin-A-treated: 22.46+/-1.27 vs control: 10.21+/-1.65, T(4) = 9.06, p = 0.004) as estimated by the HOMA-IR. Furthermore, fetuin-A induced adipose tissue mRNA expression of the inflammatory genes Il6 and Tnf 174- and 27-fold (ANOVA, F(9,7) = 7.12, p = 0.02, and F(9,7) = 12.38, p = 0.005, respectively, Figure 2A,B). This was accompanied by a 58% decrease in adipose tissue Adipoq mRNA content as compared to control (ANOVA, F(9,7) = 6.15, p = 0.038, Figure 2C), that showed a strong trend after correction for multiple comparison (p = 0.06). To validate these findings on Adipoq mRNA expression, we repeated the experiment and additionally measured serum adiponectin. In the second experiment, treatment of mice with a commercially available bovine fetuin-A (0.75 mg/g body weight) provoked a significant 45% decrease in perigonadal adipose tissue Adipoq mRNA content as compared to baseline (T(4) = 4.30, p = 0.006), whereas no effect was seen in diluent-treated control animals (p = 0.48). Concomitantly, serum adiponectin levels significantly decreased in fetuin-A-treated (T(4) = 2.58, p = 0.031), but not in diluent-treated mice (p = 0.41). To assess specificity for adiponectin, we additionally quantified adipose tissue mRNA expression of other adipokine genes such as Lep (encoding leptin) and Rbp4 (encoding retinol-binding protein 4). Fetuin-A did not modulate Lep (Figure 2D) or Rbp4 (data not shown) mRNA expression. Treatment of mice with human albumin (0.5 mg/g body weight) did not significantly alter the expression of all these genes (all p>0.2, Figure 2A-D).
###end p 36
###begin title 37
###xml 60 64 <span type="species:ncbi:10090">mice</span>
Cytokine and adipokine mRNA expression in adipose tissue of mice.
###end title 37
###begin p 38
###xml 29 32 29 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il6</italic>
###xml 38 41 38 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tnf</italic>
###xml 47 53 47 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Adipoq</italic>
###xml 63 66 63 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lep</italic>
###xml 79 83 <span type="species:ncbi:10090">mice</span>
###xml 111 116 <span type="species:ncbi:9606">human</span>
###xml 150 155 <span type="species:ncbi:9606">human</span>
Adipose tissue expression of Il6 (A), Tnf (B), Adipoq (C), and Lep (D) mRNA in mice after bolus treatment with human fetuin-A (0.5 mg/g body weight), human albumin (0.5 mg/g body weight), or diluent (control) for 8 h. Cellular mRNA contents were corrected for 28S-rRNA (RAU = relative arbitrary units). Data are given as means+/-SEM. Data were analyzed by ANOVA, followed by Dunnett's test.
###end p 38
###begin title 39
###xml 61 66 <span type="species:ncbi:9606">human</span>
Effect of fetuin-A on ADIPOQ and cytokine mRNA expression of human in vitro differentiated adipocytes
###end title 39
###begin p 40
###xml 31 37 31 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Adipoq</italic>
###xml 144 152 144 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 314 320 310 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADIPOQ</italic>
###xml 419 427 415 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001765-g003">Figure 3</xref>
###xml 542 545 538 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF</italic>
###xml 558 561 554 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL6</italic>
###xml 574 578 570 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCL2</italic>
###xml 590 594 586 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
###xml 954 963 950 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001765.s001">Figure S1</xref>
###xml 168 173 <span type="species:ncbi:9606">human</span>
###xml 207 213 <span type="species:ncbi:9913">bovine</span>
###xml 217 222 <span type="species:ncbi:9606">human</span>
###xml 459 464 <span type="species:ncbi:9606">human</span>
###xml 751 756 <span type="species:ncbi:9606">human</span>
###xml 776 781 <span type="species:ncbi:9606">human</span>
###xml 819 824 <span type="species:ncbi:9606">human</span>
###xml 882 887 <span type="species:ncbi:9606">human</span>
###xml 1211 1217 <span type="species:ncbi:9606">humans</span>
To test whether suppression of Adipoq mRNA expression by fetuin-A is a direct effect on adipocytes and is not restricted to rodents, we treated in vitro differentiated human adipocytes from four donors with bovine or human fetuin-A (300 microg/ml) for 24 h. These procedures resulted in 30- and 50-% reductions of ADIPOQ mRNA expression, respectively (T(3) = -3.87, p = 0.001 and T(3) = -3.54, p = 0.016, respectively, Figure 3). In analogy to our results in human THP1 monocytes, fetuin-A induced inflammatory markers in adipocytes as well (TNF: p = 0.007; IL6: p = 0.035; CCL2: p = 0.03; IL1B: p = 0.068, data not shown). To further investigate whether paracrine or autocrine effects of fetuin-A exist, we determined the fetuin-A mRNA expression in human THP1 monocytes and human adipose tissue and for comparison in human liver. While fetuin-A was expressed in liver tissue from human donors, it was not expressed in THP1 monocytes or adipose tissue (Figure S1). Furthermore, fetuin-A expression was not detected in adipose tissue from obese and insulin resistant Pima Indians (personal communication Dr. Paska Permana) suggesting that these conditions do not induce fetuin-A expression in adipose tissue in humans. Thus, these data strongly support that the endocrine action of fetuin-A mediates the aforementioned effects.
###end p 40
###begin title 41
###xml 40 45 <span type="species:ncbi:9606">human</span>
Adiponectin mRNA expression in cultured human adipocytes.
###end title 41
###begin p 42
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADIPOQ</italic>
###xml 32 40 32 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 26 31 <span type="species:ncbi:9606">human</span>
###xml 88 94 <span type="species:ncbi:9913">bovine</span>
###xml 103 108 <span type="species:ncbi:9606">human</span>
ADIPOQ mRNA expression of human in vitro differentiated adipocytes after treatment with bovine (A) and human (B) fetuin-A for 24 h. Cellular mRNA contents were corrected for 28S-rRNA. Data from adipocyte cultures of four donors are presented. Data were analyzed by Student's t-test.
###end p 42
###begin title 43
Relationship of plasma fetuin-A with circulating markers of inflammation and plasma adiponectin
###end title 43
###begin p 44
###xml 132 139 132 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 466 473 466 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001765-t002">Table 2</xref>
###xml 673 677 667 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Kershaw1">[30]</xref>
###xml 125 131 <span type="species:ncbi:9606">humans</span>
###xml 298 306 <span type="species:ncbi:9606">patients</span>
To investigate whether plasma fetuin-A is associated with circulating markers of inflammation and circulating adiponectin in humans in vivo, we analyzed cross-sectional data from 122 subjects including 80 subjects with normal glucose tolerance, 40 subjects with impaired glucose tolerance, and two patients with newly diagnosed and untreated type 2 diabetes. The subjects covered a wide range of age, body fat content, waist circumference, and circulating fetuin-A (Table 2). Plasma fetuin-A was not associated with circulating IL-6 and TNF-alpha (both p >/= 0.82). This finding was not unexpected since both cytokines act in a paracrine, rather than in a systemic fashion [30]. However, a positive correlation between circulating fetuin-A and hsCRP, a systemic marker of subclinical inflammation, was detected (r = 0.26, p = 0.01, n = 94 with hsCRP above the detection limit of the ELISA). Furthermore, circulating fetuin-A and adiponectin were negatively correlated with each other (r = -0.28, p = 0.02).
###end p 44
###begin title 45
Demographics and metabolic characteristics of the subjects
###end title 45
###begin p 46
Values are mean (SE);
###end p 46
###begin p 47
available in 49 subjects
###end p 47
###begin p 48
###xml 210 217 210 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001765-t003">Table 3</xref>
###xml 381 388 381 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001765-t003">Table 3</xref>
###xml 443 444 443 444 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 467 474 467 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001765-t003">Table 3</xref>
###xml 565 566 565 566 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 682 689 682 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001765-t003">Table 3</xref>
Next, we assessed the role of plasma fetuin-A as a determinant of circulating adiponectin and its independence of other known determinants of circulating adiponectin by multivariate linear regression analysis (Table 3). Circulating adiponectin was chosen as the dependent variable, and gender, age, body fat, and waist circumference were used as covariates and added step by step (Table 3, models 1-4). This procedure gradually increased the r2 of the model to 0.39 (Table 3, model 4). Inclusion of plasma fetuin-A as an additional covariate further increased the r2 to 0.42, and plasma fetuin-A concentration turned out to be an independent determinant of circulating adiponectin (Table 3, model 5).
###end p 48
###begin title 49
###xml 43 49 <span type="species:ncbi:9606">humans</span>
Determinants of circulating adiponectin in humans in multivariate linear regression models
###end title 49
###begin title 50
Relationship between fetuin-A and multimeric forms of adiponectin
###end title 50
###begin p 51
###xml 204 208 204 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Tsao1">[31]</xref>
###xml 807 811 801 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Stefan2">[24]</xref>
###xml 875 884 869 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001765-g004">Figure 4A</xref>
###xml 916 925 910 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001765-g004">Figure 4B</xref>
###xml 936 945 930 939 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001765-g004">Figure 4C</xref>
###xml 990 999 984 993 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001765-g004">Figure 4D</xref>
###xml 381 384 <span type="species:ncbi:9606">men</span>
###xml 389 394 <span type="species:ncbi:9606">women</span>
Plasma adiponectin circulates in several multimeric forms, i.e. trimeric low molecular weight (LMW), hexameric middle molecular weight (MMW) as well as more complex high molecular weight (HMW) structures [31]. We assessed whether fetuin-A affects the formation of a certain form in a subgroup of 49 subjects who underwent the clamp and had plasma samples stored at -80degreesC (21 men, 28 women; 23-64 years; 16.0-50.0% body fat; 68-119 cm waist circumference). In this subgroup, total plasma adiponectin was positively correlated with hyperinsulinemic euglycemic clamp-derived insulin sensitivity adjusted for gender, age, and body fat (r = 0.40, p = 0.005). Furthermore, plasma fetuin-A tended to negatively correlate with the adjusted insulin sensitivity (r = -0.25, p = 0.08) reflecting our recent data [24]. Plasma fetuin-A correlated negatively with total adiponectin (Figure 4A) and, in particular, with HMW (Figure 4B) and MMW (Figure 4C) adiponectin, but not with LMW adiponectin (Figure 4D).
###end p 51
###begin title 52
###xml 74 80 <span type="species:ncbi:9606">humans</span>
Relationships between circulating fetuin-A and circulating adiponectin in humans.
###end title 52
###begin p 53
###xml 125 130 <span type="species:ncbi:9606">human</span>
Relationship between plasma levels of fetuin-A with total adiponectin and adiponectin's multimeric forms (A-D) in 49 healthy human subjects after adjustment of log-transformed data for age, sex, and percentage of body fat by multivariate linear regression analysis. The regression coefficients as well as the p-value are indicated (HMW-high molecular weight; LMW-low molecular weight; MMW-middle molecular weight).
###end p 53
###begin title 54
Discussion
###end title 54
###begin p 55
###xml 69 73 69 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Pedersen1">[32]</xref>
###xml 230 234 230 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-JahnenDechent1">[33]</xref>
###xml 236 240 236 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Schafer1">[34]</xref>
###xml 391 395 391 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Ketteler1">[35]</xref>
###xml 586 589 586 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Auberger1">[3]</xref>
###xml 590 593 590 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Mathews2">[7]</xref>
###xml 713 716 713 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Mathews3">[8]</xref>
###xml 287 293 <span type="species:ncbi:9606">humans</span>
###xml 366 374 <span type="species:ncbi:9606">patients</span>
###xml 617 621 <span type="species:ncbi:10090">mice</span>
Fetuin-A is a major plasma glycoprotein which was discovered in 1944 [32]. For a long time, its biological function remained obscure. Using targeted gene disruption, fetuin-A was recently reported to inhibit ectopic calcification [33], [34]. In keeping with this, fetuin-A deficiency in humans was found to be associated with vascular calcification and mortality in patients on hemodialysis [35]. However, fetuin-A might exert more functions: several studies demonstrated that fetuin-A can act as a natural inhibitor of the insulin receptor tyrosine kinase in liver and skeletal muscle [3]-[7], and fetuin-A knockout mice display improved insulin sensitivity and are resistant to weight gain upon a high-fat diet [8].
###end p 55
###begin p 56
###xml 165 169 165 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Dahlman1">[10]</xref>
###xml 299 305 299 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADIPOQ</italic>
###xml 331 335 331 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AHSG</italic>
###xml 439 445 439 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADIPOQ</italic>
###xml 451 455 451 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Pollin1">[23]</xref>
###xml 635 639 635 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Stefan2">[24]</xref>
###xml 641 645 641 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Mori1">[25]</xref>
###xml 759 763 759 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Trujillo1">[27]</xref>
###xml 863 867 863 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Mori2">[36]</xref>
###xml 261 266 <span type="species:ncbi:9606">human</span>
Besides the effects of fetuin-A on muscle and liver insulin signalling, there is increasing evidence that fetuin-A is important for insulin action in adipose tissue [10]. Moreover, the variability of plasma adiponectin levels is largely explained by a locus on human chromosome 3q27 harbouring both ADIPOQ and, in direct vicinity, AHSG. It is of note that not all variability in plasma adiponectin is explained by genetic variation of the ADIPOQ gene [23]. This led us to investigate whether fetuin-A regulates adiponectin production and, thus, may explain the recently reported association between fetuin-A and the metabolic syndrome [24], [25]. In addition, the metabolic syndrome and hypoadiponectinemia are strongly associated with low-grade inflammation [27]. Furthermore, high circulating fetuin-A was found to be associated with carotid arterial stiffness [36], a functional property of atherosclerosis that is accompanied by subclinical inflammation. Therefore, we further tested whether fetuin-A treatment affects expression of inflammatory cytokines, a critical step in the generation of low-grade inflammation.
###end p 56
###begin p 57
###xml 164 172 164 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 298 302 298 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Weisberg1">[37]</xref>
###xml 304 308 304 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Xu1">[38]</xref>
###xml 349 357 349 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo,</italic>
###xml 420 423 420 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il6</italic>
###xml 428 431 428 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tnf</italic>
With the present report, we provide novel data that highly purified fetuin-A exerts strong pro-inflammatory effects as it provoked cytokine expression in monocytes in vitro. The latter are known to infiltrate hypertrophic adipose tissue and to essentially contribute to adipose tissue inflammation [37], [38]. In addition, we found that, in animals in vivo, fetuin-A treatment increased adipose tissue RNA expression of Il6 and Tnf 174- and 27-fold, respectively.
###end p 57
###begin p 58
###xml 130 136 130 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Adipoq</italic>
###xml 210 213 210 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lep</italic>
###xml 218 222 218 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rbp4</italic>
###xml 297 303 297 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Adipoq</italic>
###xml 384 390 384 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Adipoq</italic>
###xml 441 445 441 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Lyles1">[39]</xref>
###xml 577 583 577 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADIPOQ</italic>
###xml 598 606 598 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 115 119 <span type="species:ncbi:10090">mice</span>
###xml 622 627 <span type="species:ncbi:9606">human</span>
Besides the effects of fetuin-A on the expression of these inflammatory cytokines, administration of fetuin-A into mice repressed Adipoq mRNA expression in adipose tissue and decreased circulating adiponectin. Lep and Rbp4 mRNA expression were not affected by fetuin-A, and albumin did not impair Adipoq mRNA expression. These findings provide evidence that the effect of fetuin-A on Adipoq expression is not due to a general trophic effect [39]. Furthermore, fetuin-A directly affected adipocyte gene expression and these findings were not restricted to rodents: it repressed ADIPOQ expression of in vitro differentiated human adipocytes.
###end p 58
###begin p 59
###xml 24 32 24 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 280 285 280 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 287 291 287 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Ix1">[26]</xref>
###xml 171 177 <span type="species:ncbi:9606">humans</span>
Based on these findings in vitro and in animals, we further investigated whether circulating fetuin-A was related to low-grade inflammation and circulating adiponectin in humans. Indeed, plasma fetuin-A levels correlated positively with hsCRP levels, as reported previously by Ix et al. [26].
###end p 59
###begin p 60
###xml 163 167 163 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Ruminy1">[40]</xref>
###xml 802 808 802 808 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 808 812 808 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Ix1">[26]</xref>
###xml 600 606 <span type="species:ncbi:9606">humans</span>
These findings are somewhat unexpected because CRP is up-regulated in inflammatory states while acute inflammation down-regulates fetuin-A expression in the liver [40]. Whether, the latter effect is transient and/or reflects compensational mechanisms, needs to be determined. Furthermore, plasma fetuin-A levels correlated negatively with plasma adiponectin levels. In addition, besides other determinants of adiponectin levels, plasma fetuin-A levels were identified as a contributor to the variability in circulating adiponectin. Of note, the observed relationships of fetuin-A with adiponectin in humans were not very strong, nevertheless, they remained statistically significant after adjustment for established determinants of plasma adiponectin levels. This finding supports the assumption of Ix et al.[26] that the strong relationship between plasma fetuin-A levels and the metabolic syndrome may be a result of fetuin-A-induced suppression of adiponectin production.
###end p 60
###begin p 61
###xml 183 187 183 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Hara1">[41]</xref>
###xml 355 359 355 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Hara1">[41]</xref>
###xml 360 364 360 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-LaraCastro1">[43]</xref>
###xml 568 572 568 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Tsao1">[31]</xref>
In addition, fetuin-A was specifically associated with HMW and MMW forms of adiponectin, but not with the LMW form. HMW adiponectin is reported to be the most active adiponectin form [41] and represents, among all multimeric forms of adiponectin, the major determinant of insulin resistance, an atherogenic lipoprotein profile, and the metabolic syndrome [41]-[43]. How fetuin-A determines the assembly of trimeric adiponectin into hexameric MMW and higher-order HMW structures, a process that is supposed to occur during the entry of adiponectin into the bloodstream [31], is currently unknown and needs further investigation.
###end p 61
###begin p 62
###xml 214 220 214 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADIPOQ</italic>
###xml 347 353 347 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADIPOQ</italic>
###xml 836 840 816 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Schmidt1">[11]</xref>
###xml 610 614 <span type="species:ncbi:10090">mice</span>
So far, no information is available on fetuin-A-specific cell surface receptors and intracellular signaling pathways making it difficult to assess the molecular mechanisms underlying fetuin-A-induced repression of ADIPOQ expression in adipocytes as well as fetuin-A-mediated induction of cytokine expression in monocytes and adipocytes. Since the ADIPOQ gene is under the control of the transcription factor peroxisome proliferator-activated receptor (PPAR) gamma, we also assessed whether PPARgamma expression was altered by fetuin-A treatment. Whereas fetuin-A reduced adipose tissue PPARgamma expression in mice in vivo, PPARgamma expression of adipocytes was not affected (data not shown). The down-regulation of adiponectin and possibly PPARgamma expression, appears contradicting to the reported pro-adipogenic effect of fetuin-A [11]. However, this observation may be due to differential effects of fetuin-A on mature adipocytes and pre-adipocytes, respectively.
###end p 62
###begin p 63
###xml 173 177 169 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Fasshauer1">[44]</xref>
###xml 178 182 174 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Sopasakis1">[49]</xref>
Since we observed a strong effect of fetuin-A on cytokine expression, and IL-6 and TNF-alpha are well-described negative regulators of adiponectin expression and production [44]-[49], we suppose that fetuin-A-induced impairment of adiponectin synthesis may be at least partially mediated by effects of fetuin-A on IL-6 and TNF-alpha production. Whether this is an exclusive mechanism, or whether fetuin-A regulates adiponectin expression and secretion independently of cytokine production, needs to be determined in future studies.
###end p 63
###begin p 64
###xml 271 275 271 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Roden1">[50]</xref>
###xml 338 342 338 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Lin1">[51]</xref>
###xml 354 358 354 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Stefan2">[24]</xref>
###xml 508 511 508 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Auberger1">[3]</xref>
###xml 512 515 512 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Mathews2">[7]</xref>
###xml 662 666 662 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Chan1">[52]</xref>
###xml 771 775 771 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Lam1">[53]</xref>
###xml 867 871 867 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Santoliquido1">[54]</xref>
###xml 996 999 996 999 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001765-Mathews3">[8]</xref>
###xml 333 337 <span type="species:ncbi:10116">rats</span>
###xml 347 353 <span type="species:ncbi:9606">humans</span>
###xml 932 936 <span type="species:ncbi:10090">mice</span>
Together, the results presented in this work advance our understanding of the role of fetuin-A in the pathophysiology of insulin resistance, atherosclerosis, and the metabolic syndrome. Hepatic steatosis that is strongly related to insulin resistance and type 2 diabetes [50], associates with enhanced hepatic fetuin-A production in rats [51] and humans [24]. Elevated circulating levels of fetuin-A negatively affect whole-body insulin sensitivity (i) by impairment of insulin signaling in muscle and liver [3]-[7] and (ii) by triggering inflammation in adipose tissue and suppression of adiponectin production. Generation of an atherogenic lipoprotein profile [52], induction of inflammatory cytokines as well as suppression of the atheroprotective hormone adiponectin [53], therefore, represent plausible molecular pathways linking fatty liver and atherosclerosis [54]. In addition, based on the findings from fetuin-A deficient mice that remain lean and insulin sensitive fed a high-fat diet [8], fetuin-A may have long-term effects on energy expenditure and lipid oxidation, independent of the aforementioned mechanisms.
###end p 64
###begin p 65
###xml 124 130 <span type="species:ncbi:9606">humans</span>
In conclusion, we found that fetuin-A induces low-grade inflammation and represses adiponectin production in animals and in humans. These data provide novel evidence on the role of fatty liver in the pathophysiology of insulin resistance and atherosclerosis.
###end p 65
###begin title 66
Supporting Information
###end title 66
###begin p 67
(0.50 MB TIF)
###end p 67
###begin p 68
Click here for additional data file.
###end p 68
###begin p 69
###xml 28 40 <span type="species:ncbi:9606">participants</span>
The authors thank all study participants for their cooperation. We gratefully acknowledge the excellent technical assistance of Anna Bury and Heike Luz who were involved in the clinical tests and Melanie Weisser and Alke Guirguis who were involved in the analytical procedures.
###end p 69
###begin title 70
References
###end title 70
###begin article-title 71
###xml 45 51 <span type="species:ncbi:9913">bovine</span>
The complete cDNA and amino acid sequence of bovine fetuin. Its homology with alpha 2HS glycoprotein and relation to other members of the cystatin superfamily.
###end article-title 71
###begin article-title 72
Tissue distribution and activity testing suggest a similar but not identical function of fetuin-B and fetuin-A.
###end article-title 72
###begin article-title 73
Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activity.
###end article-title 73
###begin article-title 74
###xml 51 54 <span type="species:ncbi:10116">rat</span>
###xml 122 125 <span type="species:ncbi:10116">rat</span>
The nucleotide and partial amino acid sequences of rat fetuin. Identity with the natural tyrosine kinase inhibitor of the rat insulin receptor.
###end article-title 74
###begin article-title 75
###xml 53 58 <span type="species:ncbi:9606">human</span>
Serum alpha 2-HS-glycoprotein is an inhibitor of the human insulin receptor at the tyrosine kinase level.
###end article-title 75
###begin article-title 76
###xml 0 6 <span type="species:ncbi:9913">Bovine</span>
Bovine fetuin is an inhibitor of insulin receptor tyrosine kinase.
###end article-title 76
###begin article-title 77
Alpha2-HSG, a specific inhibitor of insulin receptor autophosphorylation, interacts with the insulin receptor.
###end article-title 77
###begin article-title 78
###xml 62 66 <span type="species:ncbi:10090">mice</span>
Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene.
###end article-title 78
###begin article-title 79
A synonymous coding polymorphism in the alpha2-Heremans-schmid glycoprotein gene is associated with type 2 diabetes in French Caucasians.
###end article-title 79
###begin article-title 80
alpha2-Heremans-Schmid glycoprotein gene polymorphisms are associated with adipocyte insulin action.
###end article-title 80
###begin article-title 81
Adipose conversion of 3T3-L1 cells in a serum-free culture system depends on epidermal growth factor, insulin-like growth factor I, corticosterone, and cyclic AMP.
###end article-title 81
###begin article-title 82
Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.
###end article-title 82
###begin article-title 83
Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia.
###end article-title 83
###begin article-title 84
###xml 197 203 <span type="species:ncbi:9606">humans</span>
Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans.
###end article-title 84
###begin article-title 85
Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism.
###end article-title 85
###begin article-title 86
Adiponectin in youth: relationship to visceral adiposity, insulin sensitivity, and beta-cell function.
###end article-title 86
###begin article-title 87
###xml 63 66 <span type="species:ncbi:9606">men</span>
Plasma adiponectin levels and risk of myocardial infarction in men.
###end article-title 87
###begin article-title 88
Plasma adiponectin levels and sonographic phenotypes of subclinical carotid artery atherosclerosis: data from the SAPHIR Study.
###end article-title 88
###begin article-title 89
###xml 59 62 <span type="species:ncbi:9606">men</span>
Adiponectin and future coronary heart disease events among men with type 2 diabetes.
###end article-title 89
###begin article-title 90
Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers.
###end article-title 90
###begin article-title 91
Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24.
###end article-title 91
###begin article-title 92
Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome.
###end article-title 92
###begin article-title 93
Linkage of plasma adiponectin levels to 3q27 explained by association with variation in the APM1 gene.
###end article-title 93
###begin article-title 94
###xml 120 126 <span type="species:ncbi:9606">humans</span>
Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans.
###end article-title 94
###begin article-title 95
Association of serum fetuin-A with insulin resistance in type 2 diabetic and nondiabetic subjects.
###end article-title 95
###begin article-title 96
###xml 20 25 <span type="species:ncbi:9606">human</span>
Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study.
###end article-title 96
###begin article-title 97
Adipose tissue-derived factors: impact on health and disease.
###end article-title 97
###begin article-title 98
###xml 66 71 <span type="species:ncbi:9606">human</span>
Evidence for a local renin angiotensin system in primary cultured human preadipocytes.
###end article-title 98
###begin article-title 99
###xml 130 133 <span type="species:ncbi:9606">man</span>
Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.
###end article-title 99
###begin article-title 100
Adipose tissue as an endocrine organ.
###end article-title 100
###begin article-title 101
Oligomerization state-dependent activation of NF-kappa B signaling pathway by adipocyte complement-related protein of 30 kDa (Acrp30).
###end article-title 101
###begin article-title 102
Fetuin, a new globulin isolated from serum.
###end article-title 102
###begin article-title 103
Systemic inhibition of spontaneous calcification by the serum protein alpha 2-HS glycoprotein/fetuin.
###end article-title 103
###begin article-title 104
The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification.
###end article-title 104
###begin article-title 105
###xml 92 100 <span type="species:ncbi:9606">patients</span>
Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study.
###end article-title 105
###begin article-title 106
Association of serum fetuin-A with carotid arterial stiffness.
###end article-title 106
###begin article-title 107
Obesity is associated with macrophage accumulation in adipose tissue.
###end article-title 107
###begin article-title 108
Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance.
###end article-title 108
###begin article-title 109
Regulation of NCAM by growth factors in serum-free myotube cultures.
###end article-title 109
###begin article-title 110
Gene transcription in hepatocytes during the acute phase of a systemic inflammation: from transcription factors to target genes.
###end article-title 110
###begin article-title 111
Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome.
###end article-title 111
###begin article-title 112
Serum high molecular weight complex of adiponectin correlates better with glucose tolerance than total serum adiponectin in Indo-Asian males.
###end article-title 112
###begin article-title 113
Adiponectin multimeric complexes and the metabolic syndrome trait cluster.
###end article-title 113
###begin article-title 114
Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes.
###end article-title 114
###begin article-title 115
###xml 150 155 <span type="species:ncbi:9606">human</span>
Influences of ionomycin, dibutyryl-cycloAMP and tumour necrosis factor-alpha on intracellular amount and secretion of apM1 in differentiating primary human preadipocytes.
###end article-title 115
###begin article-title 116
###xml 102 108 <span type="species:ncbi:9606">humans</span>
Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans.
###end article-title 116
###begin article-title 117
Increased expression of TNF-alpha, IL-6, and IL-8 in HALS: implications for reduced adiponectin expression and plasma levels.
###end article-title 117
###begin article-title 118
Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes.
###end article-title 118
###begin article-title 119
High local concentrations and effects on differentiation implicate interleukin-6 as a paracrine regulator.
###end article-title 119
###begin article-title 120
Mechanisms of Disease: hepatic steatosis in type 2 diabetes-pathogenesis and clinical relevance.
###end article-title 120
###begin article-title 121
Differential expression of insulin receptor tyrosine kinase inhibitor (fetuin) gene in a model of diet-induced obesity.
###end article-title 121
###begin article-title 122
Dyslipidemia in visceral obesity: mechanisms, implications, and therapy.
###end article-title 122
###begin article-title 123
Adiponectin: protection of the endothelium.
###end article-title 123
###begin article-title 124
Hepatic steatosis and vascular disease.
###end article-title 124
###begin p 125
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 125
###begin p 126
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: The study was partially supported grants from the Deutsche Forschungsgemeinschaft(KFO 114 and HE 3653/3-1) and the European Community's frame program FP6 EUGENE2 (LSHM-CT-2004-512013). The funders had a limited influence on the design of the study but no influence on the conduct of the study, on the collection, analysis, and interpretation of the data, and on the preparation, review, or approval of the manuscript.
###end p 126

